6Duffner F,Ritz R,Freudenstein D,et al.Specific intensity imaging for glioblastoma and neural cell cultures with 5-aminolevulinic acid-derlved protoperphyrin IX[J].J Neurooncol,2005,71(2):107-111.
7Stummer W,Novotny A,Stepp H,et al.Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevu-linic acid-induced porphyrins:a prospective study in 52 Consecutive Patients[J].J Neurosurg.2000,93(6):1003-1013.
9Castro MG,Cowen B,Williamson 1K,et al.Current and future strategies for the treatment of malignant brain tumors[J].Phamacol Ther,2003,98(1):71-108.
10Nishihori T,Shirato H,Aoyama H,et al.Three-dimensional conformal radiotherapy for astrocytic tumors involving the eloquent area in children and young adultsEJ].J Nenrooncol,2002,60(2):177-183.
6Schuler G,Steinman RM.Dendritic cells as adjuvants for immune-mediated resistance to tumors.J Exp Med,1997,186:11831.
7Legler JM,Ries LA,Smith MA,et al.Cancer surveillance series[corrected]:brain and other central nervous system cancers.Recent trends in incidence and mortality.J Natl Cancer Inst,1999,91:1382-1390.
8Hamburger AB,Crotty LE,Archer GE,et al.Bone marrowderived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma.J Neuroimmunol,2000,103:16-25.
9Chi DD,Merchant RE,Rand R,et al.Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas.Am J Pathol,1997,150:2143-2152.
10Reardon DA,Akabani G,Coleman RE,et al.Phase Ⅱ trial of murine (131) Ⅰ-labeled antitenascin monoclonal antibody 81C6administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas.J Clin Oncol,2002,20:1389-1397.
